文献速递瘢痕与激光

miR-542-3p靶向ATG7调控人瘢痕疙瘩成纤维细胞活力及促纤维化标志物表达

miR-542-3p targets ATG7 to regulate viability and profibrotic marker expression in human keloid fibroblasts.
PubMed 文献 · J Burn Care Res · 2026-08-08

本研究探讨miR-542-3p在瘢痕疙瘩成纤维细胞中的作用及ATG7是否为其直接下游介质。结果显示miR-542-3p在HKFs中显著上调,抑制miR-542-3p可降低HKF活力、增加凋亡并减少胶原I、胶原III和α-SMA蛋白水平。双荧光素酶实验证实miR-542-3p直接结合ATG7的3'-UTR,且ATG7敲低可减弱miR-542-3p抑制的抗纤维化效应。结论为miR-542-3p通过靶向ATG7促进瘢痕疙瘩成纤维细胞的促存活、促纤维化表型。

要点

  • miR-542-3p在瘢痕疙瘩成纤维细胞中显著上调。
  • 抑制miR-542-3p降低HKF活力、增加凋亡并减少胶原I/III和α-SMA。
  • miR-542-3p直接靶向ATG7 3'-UTR,ATG7敲低减弱其抗纤维化效应。

核心结论

  • miR-542-3p通过直接靶向ATG7促进瘢痕疙瘩成纤维细胞的促存活、促纤维化表型。
  • miR-542-3p/ATG7轴可能是瘢痕疙瘩纤维化进一步研究的候选通路。

研究设计与样本

  • 使用人瘢痕疙瘩成纤维细胞(HKFs)和人皮肤成纤维细胞(HSFs)进行体外研究。
  • HKFs转染miR-542-3p mimic/inhibitor及相应对照,并采用ATG7敲低(si-ATG7)及上位性实验评估功能依赖性。

主要发现

  • miR-542-3p在HKFs中较HSFs显著上调。
  • 抑制miR-542-3p降低HKF活力并增加凋亡,过表达miR-542-3p呈相反趋势。
  • miR-542-3p正向调控胶原I、胶原III和α-SMA蛋白水平。
  • 双荧光素酶实验证实miR-542-3p直接结合ATG7 3'-UTR,且ATG7蛋白丰度受miR-542-3p反向调控。
  • ATG7敲低增加HKF活力、升高促纤维化标志物表达,并减弱miR-542-3p抑制诱导的抗纤维化效应。

临床怎么用

  • 本研究为体外机制探索,尚不能直接指导临床决策。
  • miR-542-3p/ATG7轴可作为瘢痕疙瘩纤维化机制研究的候选方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Keloids are characterized by persistent fibroblast activation and excessive extracellular matrix (ECM) accumulation. This study aimed to clarify the role of miR-542-3p in keloid fibroblasts and to determine whether ATG7 functions as a direct downstream mediator regulating fibroblast viability/apoptosis and profibrotic protein expression. Human keloid fibroblasts (HKFs) and human skin fibroblasts (HSFs) were used. miR-542-3p expression was quantified by RT-qPCR. HKFs were transfected with miR-542-3p mimic/inhibitor and corresponding negative controls. Cell viability was assessed using CCK-8, and apoptosis was evaluated by Annexin V-FITC/PI flow cytometry. Protein levels of collagen I, collagen III and α-SMA were examined by western blotting. Direct targeting of ATG7 by miR-542-3p was tested using wild-type/mutant ATG7 3'-UTR dual-luciferase reporter assays. ATG7 knockdown (si-ATG7) and epistasis (miR-542-3p inhibitor ± si-ATG7) experiments were performed to assess functional dependency. miR-542-3p was significantly upregulated in HKFs compared with HSFs. miR-542-3p inhibition reduced HKF viability and increased apoptosis, whereas miR-542-3p overexpression showed the opposite trend. miR-542-3p positively regulated collagen I, collagen III and α-SMA protein levels. Dual-luciferase assays confirmed that miR-542-3p directly binds the ATG7 3'-UTR, and ATG7 protein abundance was inversely regulated by miR-542-3p. Functionally, ATG7 knockdown increased HKF viability and elevated profibrotic marker expression, and it attenuated the anti-fibrotic effects induced by miR-542-3p inhibition. miR-542-3p promotes a pro-survival, profibrotic phenotype in keloid fibroblasts by directly targeting ATG7. The miR-542-3p/ATG7 axis may represent a mechanistically supported candidate pathway for further investigation in keloid fibrosis.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Zhang R, Feng J, Zhang Q, et al. miR-542-3p targets ATG7 to regulate viability and profibrotic marker expression in human keloid fibroblasts. J Burn Care Res. 2026. PMID: 42570322. doi:10.1093/jbcr/irag129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。